Skip to content

Relationship between immunity level and subclinical target organ damage in hypertension

Study on hypertension and immune status

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100054414
Enrollment
Unknown
Registered
2021-12-17
Start date
2021-12-15
Completion date
Unknown
Last updated
2022-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

Case series:No

Sponsors

Sichuan Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 35 to 80 years; 2. Patients with hypertension or healthy people.

Exclusion criteria

Exclusion criteria: 1. Cardiovascular disease (coronary heart disease, severe valvular disease, congenital heart disease, cardiomyopathy, heart failure), cerebrovascular disease; 2. Secondary hypertension, endocrine, blood and respiratory diseases, kidney diseases; 3. Peripheral vascular disease, severe retinopathy, acute infection, connective tissue disease; 4. Tumor patients who are receiving radiotherapy, chemotherapy and immunotherapy; 5. Patients who take hormone drugs for a long time.

Design outcomes

Primary

MeasureTime frame
blood pressure;electrocardiogram;Echocardiography;Carotid ultrasound;questionnaire;Immunity assessment;height;weight;body mass index;Kidney function;Fasting blood glucose;Blood lipids;Urine routine;

Secondary

MeasureTime frame
Chest imaging;Fundus examination;waistline;serum uric acid;Urine microalbumin;Urinary microalbumin / creatinine;

Countries

China

Contacts

Public ContactMa Xiaoxiang

Sichuan Provincial People's Hospital

1602276874@qq.com+86 17708130163

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 8, 2026